−0.0304USD
−4.28 MUSD
35.89 M
About Bioxytran, Inc.
Sector
CEO
David Platt
Headquarters
Needham
Website
Founded
2008
FIGI
BBG000P03775
BioXyTran, Inc. engages in the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen in tissues. Its product pipeline includes BXT-25, a drug designed to oxygenate ischemic (reduced blood flow) regions in the brain that suffered from hypoxia during a brain stroke, and BXT-252, which treats chronic wounds resulting from ischemia caused by occlusion of capillaries. The company was founded on June 9, 2008 and is headquartered in Needham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BIXT is 0.1350 USD — it has increased by 3.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bioxytran, Inc. stocks are traded under the ticker BIXT.
BIXT stock is 3.85% volatile and has beta coefficient of −0.48. Check out the list of the most volatile stocks — is Bioxytran, Inc. there?
Yes, you can track Bioxytran, Inc. financials in yearly and quarterly reports right on TradingView.
BIXT stock has risen by 4.65% compared to the previous week, the month change is a 21.62% rise, over the last year Bioxytran, Inc. has showed a 70.97% decrease.
BIXT net income for the last quarter is −800.33 K USD, while the quarter before that showed −1.05 M USD of net income which accounts for 23.52% change. Track more Bioxytran, Inc. financial stats to get the full picture.
Today Bioxytran, Inc. has the market capitalization of 11.48 M, it has increased by 26.64% over the last week.
No, BIXT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIXT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioxytran, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioxytran, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioxytran, Inc. stock shows the sell signal. See more of Bioxytran, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.